| Acinetobacter baumannii |
Acinetobacter baumannii |
Inhibition |
5.77 |
% |
10.6019/CHEMBL4513141 |
| Bacteria |
DNA |
Activity |
nan |
None |
10.1039/C6MD00384B |
| Candida albicans |
Candida albicans |
Inhibition |
1.91 |
% |
10.6019/CHEMBL4513141 |
| Canis lupus familiaris |
MDCK |
Activity |
nan |
None |
10.1016/j.ejmech.2016.10.037 |
| Canis lupus familiaris |
MDCK |
IC50 |
775000.0 |
nM |
10.1016/j.ejmech.2016.10.037 |
| Canis lupus familiaris |
MDCK |
IC50 |
1000000.0 |
nM |
10.1016/j.ejmech.2016.10.037 |
| Cryptococcus neoformans |
Cryptococcus neoformans |
Inhibition |
-1.17 |
% |
10.6019/CHEMBL4513141 |
| Escherichia coli |
Escherichia coli |
Inhibition |
6.63 |
% |
10.6019/CHEMBL4513141 |
| Homo sapiens |
786-0 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
A 172 |
IC50 |
40000.0 |
nM |
10.1016/j.ejmech.2021.113811 |
| Homo sapiens |
A2058 |
IC50 |
35500.0 |
nM |
10.1021/jm401121k |
| Homo sapiens |
A2780 |
Activity |
nan |
None |
10.1021/ml300132t |
| Homo sapiens |
A2780 |
IC50 |
8500.0 |
nM |
10.1021/jm401121k |
| Homo sapiens |
A2780 |
IC50 |
183000.0 |
nM |
10.1021/jm000950v |
| Homo sapiens |
A2780 |
IC50 |
188000.0 |
nM |
10.1021/jm000950v |
| Homo sapiens |
A2780 |
IC50 |
250000.0 |
nM |
10.1021/jm401121k |
| Homo sapiens |
A2780 |
IC50 |
250000.0 |
nM |
10.1021/ml300132t |
| Homo sapiens |
A2780 |
IC50 |
368000.0 |
nM |
10.1021/jm000950v |
| Homo sapiens |
A2780 |
IC50 |
525000.0 |
nM |
10.1021/jm000950v |
| Homo sapiens |
A2780 |
PF50 |
2.0 |
None |
10.1021/jm000950v |
| Homo sapiens |
A2780 |
PF50 |
2.8 |
None |
10.1021/jm000950v |
| Homo sapiens |
A2780 |
Ratio IC50 |
27.0 |
None |
10.1021/jm401121k |
| Homo sapiens |
A2780 |
Ratio IC50 |
27.0 |
None |
10.1021/ml300132t |
| Homo sapiens |
A2780 |
Ratio IC50 |
30.0 |
None |
10.1021/jm401121k |
| Homo sapiens |
A-375 |
IC50 |
75000.0 |
nM |
10.1021/acsmedchemlett.1c00252 |
| Homo sapiens |
A-375 |
IC50 |
nan |
None |
10.1016/j.bmcl.2018.05.035 |
| Homo sapiens |
A-431 |
IC50 |
366000.0 |
nM |
10.1016/j.ejmech.2017.05.016 |
| Homo sapiens |
A549 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
A549 |
IC50 |
250000.0 |
nM |
10.1021/ml300132t |
| Homo sapiens |
A549 |
IC50 |
nan |
None |
10.1016/j.bmcl.2018.05.035 |
| Homo sapiens |
Acetylcholinesterase |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
ACHN |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
Adenosine A1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A2a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2c adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-1 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-3 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bile salt export pump |
AC50 |
300000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bile salt export pump |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Bradykinin B1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bradykinin B2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
BT-549 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
CAKI-1 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
Canalicular multispecific organic anion transporter 1 |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Canalicular multispecific organic anion transporter 2 |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
CAPAN-1 |
TGI |
46.0 |
% |
10.1021/acsmedchemlett.8b00569 |
| Homo sapiens |
Carbonic anhydrase I |
Ki |
50000.0 |
nM |
10.1016/j.ejmech.2016.10.037 |
| Homo sapiens |
Carbonic anhydrase II |
Ki |
50000.0 |
nM |
10.1016/j.ejmech.2016.10.037 |
| Homo sapiens |
Carbonic anhydrase IX |
Ki |
50000.0 |
nM |
10.1016/j.ejmech.2016.10.037 |
| Homo sapiens |
Carbonic anhydrase XII |
Ki |
50000.0 |
nM |
10.1016/j.ejmech.2016.10.037 |
| Homo sapiens |
CCRF-CEM |
GI50 |
78342.96 |
nM |
None |
| Homo sapiens |
Cholecystokinin A receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cholecystokinin B receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
COLO 205 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
COLO 205 |
IC50 |
343000.0 |
nM |
10.1021/jm000961o |
| Homo sapiens |
COLO 205 |
Level |
1160.0 |
fM mg-1 |
10.1021/jm000961o |
| Homo sapiens |
Corticotropin releasing factor receptor 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Corticotropin releasing factor receptor 2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
DBTRG-05MG |
Activity |
22.29 |
% |
10.1021/acs.jnatprod.0c00580 |
| Homo sapiens |
DBTRG-05MG |
Activity |
22.95 |
% |
10.1021/acs.jnatprod.0c00580 |
| Homo sapiens |
DBTRG-05MG |
Activity |
23.42 |
% |
10.1021/acs.jnatprod.0c00580 |
| Homo sapiens |
DBTRG-05MG |
Activity |
24.76 |
% |
10.1021/acs.jnatprod.0c00580 |
| Homo sapiens |
DBTRG-05MG |
Activity |
25.43 |
% |
10.1021/acs.jnatprod.0c00580 |
| Homo sapiens |
DBTRG-05MG |
Activity |
31.03 |
% |
10.1021/acs.jnatprod.0c00580 |
| Homo sapiens |
DBTRG-05MG |
Activity |
34.67 |
% |
10.1021/acs.jnatprod.0c00580 |
| Homo sapiens |
DBTRG-05MG |
Activity |
35.43 |
% |
10.1021/acs.jnatprod.0c00580 |
| Homo sapiens |
DBTRG-05MG |
Activity |
40.56 |
% |
10.1021/acs.jnatprod.0c00580 |
| Homo sapiens |
DBTRG-05MG |
Activity |
42.28 |
% |
10.1021/acs.jnatprod.0c00580 |
| Homo sapiens |
DBTRG-05MG |
Activity |
43.53 |
% |
10.1021/acs.jnatprod.0c00580 |
| Homo sapiens |
DBTRG-05MG |
Activity |
53.64 |
% |
10.1021/acs.jnatprod.0c00580 |
| Homo sapiens |
DBTRG-05MG |
Activity |
nan |
None |
10.1021/acs.jnatprod.0c00580 |
| Homo sapiens |
DBTRG-05MG |
FC |
0.3 |
None |
10.1021/acs.jnatprod.0c00580 |
| Homo sapiens |
DBTRG-05MG |
FC |
0.4 |
None |
10.1021/acs.jnatprod.0c00580 |
| Homo sapiens |
DBTRG-05MG |
FC |
0.5 |
None |
10.1021/acs.jnatprod.0c00580 |
| Homo sapiens |
DBTRG-05MG |
FC |
0.7 |
None |
10.1021/acs.jnatprod.0c00580 |
| Homo sapiens |
DBTRG-05MG |
FC |
0.8 |
None |
10.1021/acs.jnatprod.0c00580 |
| Homo sapiens |
DBTRG-05MG |
FC |
1.0 |
None |
10.1021/acs.jnatprod.0c00580 |
| Homo sapiens |
DBTRG-05MG |
FC |
1.3 |
None |
10.1021/acs.jnatprod.0c00580 |
| Homo sapiens |
DBTRG-05MG |
FC |
1.4 |
None |
10.1021/acs.jnatprod.0c00580 |
| Homo sapiens |
DBTRG-05MG |
FC |
1.5 |
None |
10.1021/acs.jnatprod.0c00580 |
| Homo sapiens |
DBTRG-05MG |
FC |
1.8 |
None |
10.1021/acs.jnatprod.0c00580 |
| Homo sapiens |
DBTRG-05MG |
FC |
1.9 |
None |
10.1021/acs.jnatprod.0c00580 |
| Homo sapiens |
DBTRG-05MG |
FC |
2.0 |
None |
10.1021/acs.jnatprod.0c00580 |
| Homo sapiens |
DBTRG-05MG |
FC |
2.1 |
None |
10.1021/acs.jnatprod.0c00580 |
| Homo sapiens |
DBTRG-05MG |
FC |
2.8 |
None |
10.1021/acs.jnatprod.0c00580 |
| Homo sapiens |
DBTRG-05MG |
FC |
3.3 |
None |
10.1021/acs.jnatprod.0c00580 |
| Homo sapiens |
DBTRG-05MG |
IC50 |
119300.0 |
nM |
10.1021/acs.jnatprod.0c00580 |
| Homo sapiens |
DBTRG-05MG |
IC50 |
354700.0 |
nM |
10.1021/acs.jnatprod.0c00580 |
| Homo sapiens |
DBTRG-05MG |
IC50 |
973900.0 |
nM |
10.1021/acs.jnatprod.0c00580 |
| Homo sapiens |
Delta opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
DLD-1 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
DLD-1 |
GI50 |
500000.0 |
nM |
10.1039/C6MD00384B |
| Homo sapiens |
DLD-1 |
IC50 |
250000.0 |
nM |
10.1021/ml300132t |
| Homo sapiens |
DMS-114 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
DNA |
Activity |
57.0 |
% |
10.1016/j.ejmech.2021.113811 |
| Homo sapiens |
DNA |
Activity |
93.0 |
% |
10.1016/j.ejmech.2021.113811 |
| Homo sapiens |
DNA polymerase kappa |
Potency |
21192.3 |
nM |
None |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D4 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
dsDNA |
Activity |
nan |
None |
10.1039/C6MD00384B |
| Homo sapiens |
DU-145 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
EKVX |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
Endothelin receptor ET-A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Endothelin receptor ET-B |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Epidermal growth factor receptor erbB1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Equilibrative nucleoside transporter 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor beta |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
GABA-B receptor 1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Gamma-aminobutyric acid receptor subunit alpha-1/alpha-2/beta-2/gamma-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Gastric inhibitory polypeptide receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
GBM |
Activity |
nan |
None |
10.1016/j.bmcl.2019.07.051 |
| Homo sapiens |
GBM |
Activity |
nan |
None |
10.1016/j.bmcl.2020.127252 |
| Homo sapiens |
GBM |
Activity |
nan |
None |
10.1016/j.ejmech.2015.08.001 |
| Homo sapiens |
Ghrelin receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucagon receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
GM892A cell line |
IC50 |
7600.0 |
nM |
10.1021/jm00009a010 |
| Homo sapiens |
HaCaT |
IC50 |
75000.0 |
nM |
10.1021/acsmedchemlett.1c00252 |
| Homo sapiens |
HCC 2998 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
HCT-116 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
HCT-116 |
GI50 |
500000.0 |
nM |
10.1039/C6MD00384B |
| Homo sapiens |
HCT-116 |
IC50 |
4340.0 |
nM |
10.1016/j.bmc.2009.09.014 |
| Homo sapiens |
HCT-116 |
IC50 |
50000.0 |
nM |
10.1016/j.ejmech.2020.113149 |
| Homo sapiens |
HCT-116 |
IC50 |
250000.0 |
nM |
10.1021/jm401121k |
| Homo sapiens |
HCT-116 |
IC50 |
250000.0 |
nM |
10.1021/ml300132t |
| Homo sapiens |
HCT-15 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
HeLa |
GI50 |
50000.0 |
nM |
10.1016/j.bmcl.2014.06.007 |
| Homo sapiens |
HERG |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-0.65 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
4.06 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
HL-60 |
GI50 |
85506.67 |
nM |
None |
| Homo sapiens |
HL-60 |
IC50 |
nan |
None |
10.1016/j.bmcl.2021.128066 |
| Homo sapiens |
Homo sapiens |
DILI_Concern |
nan |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
DILI_severity_class |
4.0 |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
HOP-18 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
HOP-62 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
HOP-92 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
Hs-578T |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
Hs 683 |
Ratio IC50 |
nan |
None |
10.1016/j.ejmech.2012.06.050 |
| Homo sapiens |
HT-29 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
HT-29 |
IC50 |
250000.0 |
nM |
10.1021/ml300132t |
| Homo sapiens |
HT-29 |
IC50 |
951000.0 |
nM |
10.1021/jm000961o |
| Homo sapiens |
HT-29 |
Level |
908.0 |
fM mg-1 |
10.1021/jm000961o |
| Homo sapiens |
IGROV-1 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
K562 |
GI50 |
75857.76 |
nM |
None |
| Homo sapiens |
K562 |
IC50 |
156100.0 |
nM |
10.1016/s0960-894x(03)00553-5 |
| Homo sapiens |
Kappa opioid receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
KM12 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
KM-20L2 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
L02 |
IC50 |
nan |
None |
10.1016/j.bmcl.2018.05.035 |
| Homo sapiens |
LN-229 |
Activity |
nan |
None |
10.1016/j.bmc.2021.116533 |
| Homo sapiens |
LN-229 |
IC50 |
67810.0 |
nM |
10.1021/acs.jmedchem.1c00277 |
| Homo sapiens |
LoVo |
IC50 |
595000.0 |
nM |
10.1021/jm020259n |
| Homo sapiens |
LOX IMVI |
GI50 |
82035.15 |
nM |
None |
| Homo sapiens |
LXFL 529 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
M14 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
M19-MEL |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
Malme-3M |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
MAP kinase p38 |
FC |
1.2 |
None |
10.1021/acs.jnatprod.0c00580 |
| Homo sapiens |
MCF7 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
MCF7 |
IC50 |
800000.0 |
nM |
10.1016/s0960-894x(00)00461-3 |
| Homo sapiens |
MCF7 |
IC50 |
nan |
None |
10.1016/j.bmcl.2018.05.035 |
| Homo sapiens |
MCF7 |
IC50 |
nan |
None |
10.1016/j.bmcl.2021.128066 |
| Homo sapiens |
MCF7 |
IC50 |
nan |
None |
10.1021/acs.jnatprod.9b00580 |
| Homo sapiens |
MDA-MB-231 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
MDA-MB-231 |
IC50 |
nan |
None |
10.1016/j.bmcl.2018.05.035 |
| Homo sapiens |
MDA-MB-238 |
IC50 |
100000.0 |
nM |
10.1016/j.ejmech.2021.113811 |
| Homo sapiens |
MDA-MB-435 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
MDA-N |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
Melanocortin receptor 3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Melanocortin receptor 4 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Menin/Histone-lysine N-methyltransferase MLL |
Potency |
10000.0 |
nM |
None |
| Homo sapiens |
MOLT-4 |
GI50 |
83560.3 |
nM |
None |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Motilin receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Multidrug resistance-associated protein 4 |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M5 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscleblind-like protein 1 |
Potency |
28183.8 |
nM |
None |
| Homo sapiens |
MX1 |
Activity |
1.57 |
g |
10.1016/j.ejmech.2017.03.013 |
| Homo sapiens |
MX1 |
T/C |
38.0 |
% |
10.1016/j.ejmech.2017.03.013 |
| Homo sapiens |
MX1 |
TGI |
62.0 |
% |
10.1016/j.ejmech.2017.03.013 |
| Homo sapiens |
NCI/ADR-RES |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
NCI-H1299 |
IC50 |
100000.0 |
nM |
10.1016/j.ejmech.2021.113811 |
| Homo sapiens |
NCI-H209 |
Activity |
13.0 |
% |
10.1021/acs.jmedchem.0c01346 |
| Homo sapiens |
NCI-H209 |
Activity |
nan |
None |
10.1021/acs.jmedchem.0c01346 |
| Homo sapiens |
NCI-H209 |
TGI |
nan |
None |
10.1021/acs.jmedchem.0c01346 |
| Homo sapiens |
NCI-H226 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
NCI-H23 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
NCI-H322M |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
NCI-H460 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
NCI-H522 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
Neurokinin 1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuronal acetylcholine receptor protein alpha-4 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neurotensin receptor 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
OVCAR-3 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
OVCAR-4 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
OVCAR-5 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
OVCAR-8 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
PANC-1 |
IC50 |
250000.0 |
nM |
10.1021/ml300132t |
| Homo sapiens |
Panel NCI-60 (60 carcinoma cell lines) |
GI50 |
100000.0 |
nM |
10.1039/C6MD00384B |
| Homo sapiens |
PC-3 |
Activity |
nan |
None |
10.1016/j.bmc.2019.03.025 |
| Homo sapiens |
PC-3 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
P-glycoprotein 1 |
Activity |
nan |
None |
10.1021/acs.jmedchem.9b00282 |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4D |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Polyadenylate-binding protein 1 |
IC50 |
43450.0 |
nM |
None |
| Homo sapiens |
Polyadenylate-binding protein 1 |
IC50 |
66000.0 |
nM |
None |
| Homo sapiens |
Pregnane X receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Progesterone receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Raji |
IC50 |
175000.0 |
nM |
10.1021/jm00009a010 |
| Homo sapiens |
Receptor protein-tyrosine kinase erbB-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
RPMI-8226 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
RXF 393 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
Serine/threonine-protein kinase AKT |
FC |
0.7 |
None |
10.1021/acs.jnatprod.0c00580 |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 3a (5-HT3a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 6 (5-HT6) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 7 (5-HT7) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
SF-268 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
SF-295 |
GI |
nan |
None |
10.1021/jm201428a |
| Homo sapiens |
SF-295 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
SF-295 |
Inhibition |
29.8 |
% |
10.1016/j.ejmech.2019.111965 |
| Homo sapiens |
SF-539 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
SH-SY5Y |
Activity |
15.52 |
% |
10.1021/acs.jnatprod.1c00595 |
| Homo sapiens |
SH-SY5Y |
Activity |
41.49 |
% |
10.1021/acs.jnatprod.1c00595 |
| Homo sapiens |
SH-SY5Y |
Activity |
96.58 |
% |
10.1021/acs.jnatprod.1c00595 |
| Homo sapiens |
SH-SY5Y |
Activity |
nan |
None |
10.1016/j.ejmech.2019.03.048 |
| Homo sapiens |
SH-SY5Y |
IC50 |
50000.0 |
nM |
10.1016/j.bmcl.2018.05.035 |
| Homo sapiens |
SH-SY5Y |
IC50 |
100000.0 |
nM |
10.1021/acs.jnatprod.5b00969 |
| Homo sapiens |
SH-SY5Y |
IC50 |
393000.0 |
nM |
10.1021/acs.jnatprod.1c00595 |
| Homo sapiens |
SH-SY5Y |
IC50 |
512620.0 |
nM |
10.1021/acs.jnatprod.1c00595 |
| Homo sapiens |
SK-MEL-2 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
SK-MEL-28 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
SK-MEL-30 |
Activity |
nan |
None |
10.1016/j.ejmech.2013.09.040 |
| Homo sapiens |
SK-MEL-5 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
SK-OV-3 |
GI50 |
58748.94 |
nM |
None |
| Homo sapiens |
SN12C |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
SNB-19 |
GI50 |
35700.0 |
nM |
10.1039/C7MD00554G |
| Homo sapiens |
SNB-19 |
GI50 |
45600.0 |
nM |
10.1039/C6MD00384B |
| Homo sapiens |
SNB-19 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
SNB-19 |
GI50 |
470000.0 |
nM |
10.1039/C7MD00554G |
| Homo sapiens |
SNB-19 |
GI50 |
526000.0 |
nM |
10.1039/C6MD00384B |
| Homo sapiens |
SNB-19 |
IC50 |
37000.0 |
nM |
10.1021/jm401121k |
| Homo sapiens |
SNB-19 |
IC50 |
69870.0 |
nM |
10.1021/acs.jmedchem.1c00277 |
| Homo sapiens |
SNB-19 |
IC50 |
250000.0 |
nM |
10.1021/jm401121k |
| Homo sapiens |
SNB-19 |
RatioGI50 |
11.0 |
None |
10.1039/C6MD00384B |
| Homo sapiens |
SNB-75 |
GI |
nan |
None |
10.1021/jm201428a |
| Homo sapiens |
SNB-75 |
GI50 |
70957.78 |
nM |
None |
| Homo sapiens |
SNB-75 |
Inhibition |
40.8 |
% |
10.1016/j.ejmech.2019.111965 |
| Homo sapiens |
SNB-78 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
SR |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
SW480 |
IC50 |
nan |
None |
10.1016/j.bmcl.2021.128066 |
| Homo sapiens |
SW480 |
IC50 |
nan |
None |
10.1021/acs.jnatprod.9b00580 |
| Homo sapiens |
SW-620 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
SW-620 |
TIME |
1056.0 |
hr |
10.1021/jm8001263 |
| Homo sapiens |
T47D |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
T98G |
Activity |
50.0 |
% |
10.1016/j.ejmech.2021.113909 |
| Homo sapiens |
T98G |
Activity |
63.0 |
% |
10.1016/j.ejmech.2021.113909 |
| Homo sapiens |
T98G |
Activity |
100.0 |
% |
10.1016/j.ejmech.2021.113909 |
| Homo sapiens |
T98G |
Activity |
nan |
None |
10.1016/j.ejmech.2021.113909 |
| Homo sapiens |
T98G |
Activity |
nan |
None |
10.1021/acs.jmedchem.2c00840 |
| Homo sapiens |
T98G |
GI50 |
375000.0 |
nM |
10.1016/j.ejmech.2021.113909 |
| Homo sapiens |
T98G |
IC50 |
570000.0 |
nM |
10.1016/j.bmcl.2012.04.074 |
| Homo sapiens |
T98G |
IC50 |
879000.0 |
nM |
10.1016/j.ejmech.2012.06.050 |
| Homo sapiens |
T98G |
Ratio IC50 |
nan |
None |
10.1016/j.ejmech.2012.06.050 |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
TK-10 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
Type-1 angiotensin II receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Tyrosine-protein kinase ABL |
IC50 |
100000.0 |
nM |
10.1016/s0960-894x(03)00553-5 |
| Homo sapiens |
U-251 |
Activity |
0.49 |
% |
10.1016/j.ejmech.2021.113908 |
| Homo sapiens |
U-251 |
Activity |
1.6 |
% |
10.1016/j.ejmech.2021.113908 |
| Homo sapiens |
U-251 |
Activity |
1.73 |
% |
10.1016/j.ejmech.2021.113908 |
| Homo sapiens |
U-251 |
Activity |
96.18 |
% |
10.1016/j.ejmech.2021.113908 |
| Homo sapiens |
U-251 |
Activity |
nan |
None |
10.1021/acs.jmedchem.2c00840 |
| Homo sapiens |
U-251 |
Activity |
nan |
None |
None |
| Homo sapiens |
U-251 |
EC50 |
200000.0 |
nM |
10.1016/j.ejmech.2019.111981 |
| Homo sapiens |
U-251 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
U-251 |
IC50 |
6426.0 |
nM |
10.1016/j.ejmech.2021.113736 |
| Homo sapiens |
U-251 |
IC50 |
7284.0 |
nM |
10.1016/j.ejmech.2021.113736 |
| Homo sapiens |
U-251 |
IC50 |
12740.0 |
nM |
10.1016/j.ejmech.2021.113736 |
| Homo sapiens |
U-251 |
IC50 |
30000.0 |
nM |
10.1016/j.ejmech.2021.113908 |
| Homo sapiens |
U-251 |
IC50 |
36400.0 |
nM |
10.1016/j.bmcl.2021.128066 |
| Homo sapiens |
U-251 |
IC50 |
36400.0 |
nM |
10.1021/acs.jnatprod.9b00580 |
| Homo sapiens |
U-251 |
IC50 |
100000.0 |
nM |
10.1021/acs.jnatprod.5b00969 |
| Homo sapiens |
U-251 |
IC50 |
200000.0 |
nM |
10.1016/j.bmcl.2014.09.087 |
| Homo sapiens |
U-251 |
IC50 |
250000.0 |
nM |
10.1021/ml300132t |
| Homo sapiens |
U-251 |
IC50 |
455000.0 |
nM |
10.1016/j.bmc.2019.03.029 |
| Homo sapiens |
U-251 |
Inhibition |
nan |
% |
10.1016/j.bmc.2020.115887 |
| Homo sapiens |
U-251 |
Inhibition |
nan |
% |
10.1016/j.bmcl.2014.09.087 |
| Homo sapiens |
U373 MG |
GI50 |
68000.0 |
nM |
10.1039/C7MD00554G |
| Homo sapiens |
U373 MG |
GI50 |
72900.0 |
nM |
10.1039/C6MD00384B |
| Homo sapiens |
U373 MG |
GI50 |
369000.0 |
nM |
10.1039/C7MD00554G |
| Homo sapiens |
U373 MG |
GI50 |
395000.0 |
nM |
10.1039/C6MD00384B |
| Homo sapiens |
U373 MG |
RatioGI50 |
5.0 |
None |
10.1039/C6MD00384B |
| Homo sapiens |
U-87 MG |
Activity |
0.0 |
mm3 |
10.1021/acs.jmedchem.1c01522 |
| Homo sapiens |
U-87 MG |
Activity |
10.0 |
% |
10.1021/acs.jnatprod.1c00595 |
| Homo sapiens |
U-87 MG |
Activity |
32.44 |
% |
10.1021/acs.jnatprod.1c00595 |
| Homo sapiens |
U-87 MG |
Activity |
40.0 |
% |
10.1021/acs.jnatprod.1c00595 |
| Homo sapiens |
U-87 MG |
Activity |
57.32 |
% |
10.1021/acs.jnatprod.1c00595 |
| Homo sapiens |
U-87 MG |
Activity |
84.8 |
mm3 |
10.1021/acs.jmedchem.1c01522 |
| Homo sapiens |
U-87 MG |
Activity |
85.17 |
% |
10.1021/acs.jnatprod.1c00595 |
| Homo sapiens |
U-87 MG |
Activity |
nan |
None |
10.1021/acs.jmedchem.8b01305 |
| Homo sapiens |
U-87 MG |
EC50 |
200000.0 |
nM |
10.1016/j.ejmech.2019.111981 |
| Homo sapiens |
U-87 MG |
IC50 |
50000.0 |
nM |
10.1016/j.bmcl.2018.05.035 |
| Homo sapiens |
U-87 MG |
IC50 |
200000.0 |
nM |
10.1016/j.bmcl.2021.128371 |
| Homo sapiens |
U-87 MG |
IC50 |
640000.0 |
nM |
10.1021/acs.jnatprod.0c00038 |
| Homo sapiens |
U-87 MG |
IC50 |
1100000.0 |
nM |
10.1021/acs.jnatprod.0c00038 |
| Homo sapiens |
U-87 MG |
IC50 |
2898000.0 |
nM |
10.1021/acs.jnatprod.1c00595 |
| Homo sapiens |
U-87 MG |
IC50 |
3186000.0 |
nM |
10.1021/acs.jnatprod.1c00595 |
| Homo sapiens |
U-87 MG |
Inhibition |
nan |
% |
10.1021/acs.jmedchem.8b01305 |
| Homo sapiens |
U-87 MG |
Ratio IC50 |
0.6 |
None |
10.1021/acs.jnatprod.0c00038 |
| Homo sapiens |
U-87 MG |
TGI |
nan |
None |
10.1021/acs.jmedchem.8b01305 |
| Homo sapiens |
UACC-257 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
UACC-62 |
GI50 |
100000.0 |
nM |
None |
| Homo sapiens |
UO-31 |
GI50 |
73960.53 |
nM |
None |
| Homo sapiens |
Vascular endothelial growth factor receptor 2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V1a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
VMM39 |
Activity |
nan |
None |
None |
| Homo sapiens |
WiDr |
IC50 |
1720000.0 |
nM |
10.1016/j.ejmech.2015.04.004 |
| Homo sapiens |
WM 266-4 |
IC50 |
100000.0 |
nM |
10.1016/j.ejmech.2021.113811 |
| Homo sapiens |
XF498 |
GI50 |
100000.0 |
nM |
None |
| Klebsiella pneumoniae |
Klebsiella pneumoniae |
Inhibition |
7.88 |
% |
10.6019/CHEMBL4513141 |
| Mus musculus |
B16-F10 |
Activity |
14.0 |
% |
10.1021/jm901775y |
| Mus musculus |
B16-F10 |
Activity |
491.0 |
mm3 |
10.1021/jm901775y |
| Mus musculus |
B16-F10 |
Activity |
1198.0 |
mm3 |
10.1021/jm801171j |
| Mus musculus |
B16-F10 |
Activity |
1261.0 |
mm3 |
10.1021/jm901775y |
| Mus musculus |
B16-F10 |
Activity |
2318.0 |
mm3 |
10.1021/jm801171j |
| Mus musculus |
B16-F10 |
Activity |
2379.0 |
mm3 |
10.1021/jm901775y |
| Mus musculus |
B16-F10 |
IC50 |
75000.0 |
nM |
10.1016/j.bmc.2017.04.049 |
| Mus musculus |
B16-F10 |
IC50 |
75000.0 |
nM |
10.1021/acsmedchemlett.1c00252 |
| Mus musculus |
B16-F10 |
IC50 |
258000.0 |
nM |
10.1016/j.ejmech.2012.06.050 |
| Mus musculus |
B16-F10 |
TGI |
43.0 |
% |
10.1021/jm900697r |
| Mus musculus |
B16-F10 |
TGI |
56.0 |
% |
10.1021/jm900697r |
| Mus musculus |
B16-F10 |
TGI |
65.0 |
% |
10.1021/jm801171j |
| Mus musculus |
GL261 |
Activity |
nan |
None |
10.1016/j.ejmech.2019.03.048 |
| Mus musculus |
GL261 |
IC50 |
100000.0 |
nM |
10.1016/j.ejmech.2019.03.048 |
| Mus musculus |
Mus musculus |
Activity |
0.02 |
g |
10.1016/j.ejmech.2017.03.013 |
| Mus musculus |
Mus musculus |
Activity |
1.0 |
% |
10.1016/j.bmc.2012.06.021 |
| Mus musculus |
Mus musculus |
Activity |
2.0 |
% |
10.1016/j.bmc.2012.06.021 |
| Mus musculus |
Mus musculus |
Activity |
6.0 |
% |
10.1021/jm8001263 |
| Mus musculus |
Mus musculus |
Activity |
16.6 |
g |
10.1021/acs.jmedchem.1c01522 |
| Mus musculus |
Mus musculus |
GI |
30.0 |
% |
10.1016/j.bmc.2012.06.021 |
| Mus musculus |
TLX-5 |
IC50 |
5000.0 |
nM |
10.1021/jm00009a010 |
| Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
Inhibition |
16.54 |
% |
10.6019/CHEMBL4513141 |
| Rattus norvegicus |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Astrocyte |
Activity |
nan |
None |
10.1016/j.ejmech.2019.111981 |
| Rattus norvegicus |
Blood brain barrier |
pBBB |
2.7 |
10'-3cm/s |
10.1007/s00044-011-9649-6 |
| Rattus norvegicus |
C6 |
Activity |
nan |
None |
10.1016/j.ejmech.2021.113564 |
| Rattus norvegicus |
C6 |
Activity |
nan |
None |
10.1021/jm201428a |
| Rattus norvegicus |
C6 |
EC50 |
16500.0 |
nM |
10.1007/s00044-010-9356-8 |
| Rattus norvegicus |
C6 |
EC50 |
60460.0 |
nM |
10.1016/j.ejmech.2019.111981 |
| Rattus norvegicus |
C6 |
IC50 |
30000.0 |
nM |
10.1016/j.ejmech.2021.113908 |
| Rattus norvegicus |
C6 |
IC50 |
34000.0 |
nM |
10.1016/j.ejmech.2012.09.007 |
| Rattus norvegicus |
C6 |
IC50 |
60460.0 |
nM |
10.1016/j.bmcl.2014.09.087 |
| Rattus norvegicus |
C6 |
Inhibition |
12.0 |
% |
10.1021/acsmedchemlett.0c00285 |
| Rattus norvegicus |
C6 |
Inhibition |
nan |
% |
10.1016/j.bmcl.2014.09.087 |
| Rattus norvegicus |
C6 |
TGI |
54.83 |
% |
10.1016/j.ejmech.2021.113564 |
| Rattus norvegicus |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Cyclooxygenase-2 |
Inhibition |
nan |
% |
10.1016/j.ejmech.2021.113817 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glutamate (NMDA) receptor subunit zeta 1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Plasma |
T1/2 |
1.833 |
hr |
10.1021/jm049556d |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
nan |
None |
10.1016/j.bmcl.2016.08.064 |
| Rattus norvegicus |
RG2 |
Activity |
15.48 |
% |
10.1021/acs.jnatprod.0c00580 |
| Rattus norvegicus |
RG2 |
Activity |
18.32 |
% |
10.1021/acs.jnatprod.0c00580 |
| Rattus norvegicus |
RG2 |
Activity |
20.81 |
% |
10.1021/acs.jnatprod.0c00580 |
| Rattus norvegicus |
RG2 |
Activity |
22.12 |
% |
10.1021/acs.jnatprod.0c00580 |
| Rattus norvegicus |
RG2 |
Activity |
24.46 |
% |
10.1021/acs.jnatprod.0c00580 |
| Rattus norvegicus |
RG2 |
Activity |
26.97 |
% |
10.1021/acs.jnatprod.0c00580 |
| Rattus norvegicus |
RG2 |
Activity |
28.32 |
% |
10.1021/acs.jnatprod.0c00580 |
| Rattus norvegicus |
RG2 |
Activity |
31.81 |
% |
10.1021/acs.jnatprod.0c00580 |
| Rattus norvegicus |
RG2 |
Activity |
49.55 |
% |
10.1021/acs.jnatprod.0c00580 |
| Rattus norvegicus |
RG2 |
Activity |
52.7 |
% |
10.1021/acs.jnatprod.0c00580 |
| Rattus norvegicus |
RG2 |
Activity |
54.71 |
% |
10.1021/acs.jnatprod.0c00580 |
| Rattus norvegicus |
RG2 |
Activity |
54.73 |
% |
10.1021/acs.jnatprod.0c00580 |
| Rattus norvegicus |
RG2 |
Activity |
nan |
None |
10.1021/acs.jnatprod.0c00580 |
| Rattus norvegicus |
RG2 |
FC |
0.4 |
None |
10.1021/acs.jnatprod.0c00580 |
| Rattus norvegicus |
RG2 |
FC |
0.6 |
None |
10.1021/acs.jnatprod.0c00580 |
| Rattus norvegicus |
RG2 |
FC |
0.8 |
None |
10.1021/acs.jnatprod.0c00580 |
| Rattus norvegicus |
RG2 |
FC |
0.9 |
None |
10.1021/acs.jnatprod.0c00580 |
| Rattus norvegicus |
RG2 |
FC |
1.0 |
None |
10.1021/acs.jnatprod.0c00580 |
| Rattus norvegicus |
RG2 |
FC |
1.1 |
None |
10.1021/acs.jnatprod.0c00580 |
| Rattus norvegicus |
RG2 |
FC |
1.3 |
None |
10.1021/acs.jnatprod.0c00580 |
| Rattus norvegicus |
RG2 |
FC |
1.5 |
None |
10.1021/acs.jnatprod.0c00580 |
| Rattus norvegicus |
RG2 |
FC |
1.7 |
None |
10.1021/acs.jnatprod.0c00580 |
| Rattus norvegicus |
RG2 |
FC |
1.8 |
None |
10.1021/acs.jnatprod.0c00580 |
| Rattus norvegicus |
RG2 |
FC |
1.9 |
None |
10.1021/acs.jnatprod.0c00580 |
| Rattus norvegicus |
RG2 |
FC |
2.3 |
None |
10.1021/acs.jnatprod.0c00580 |
| Rattus norvegicus |
RG2 |
FC |
2.5 |
None |
10.1021/acs.jnatprod.0c00580 |
| Rattus norvegicus |
RG2 |
FC |
nan |
None |
10.1021/acs.jnatprod.0c00580 |
| Rattus norvegicus |
RG2 |
IC50 |
106700.0 |
nM |
10.1021/acs.jnatprod.0c00580 |
| Rattus norvegicus |
RG2 |
IC50 |
348200.0 |
nM |
10.1021/acs.jnatprod.0c00580 |
| Rattus norvegicus |
RG2 |
IC50 |
962500.0 |
nM |
10.1021/acs.jnatprod.0c00580 |
| Rattus norvegicus |
Voltage-gated L-type calcium channel alpha-1C subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Voltage-gated N-type calcium channel alpha-1B subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
4.413 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Hit score |
0.2002 |
None |
10.1101/2020.04.21.054387 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
19952.62 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
20000.0 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
-0.04 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
2.71 |
% |
10.21203/rs.3.rs-23951/v1 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition index |
-0.001889 |
None |
10.1101/2020.04.03.023846 |
| Staphylococcus aureus |
Staphylococcus aureus |
Inhibition |
8.98 |
% |
10.6019/CHEMBL4513141 |
| None |
ADMET |
Activity |
8.0 |
% |
10.1021/acsmedchemlett.8b00569 |
| None |
ADMET |
Activity |
9.0 |
% |
10.1021/acs.jmedchem.0c00821 |
| None |
ADMET |
Activity |
20.0 |
% |
10.1021/acs.jmedchem.8b01305 |
| None |
ADMET |
Activity |
nan |
None |
10.1016/j.ejmech.2021.113564 |
| None |
ADMET |
Activity |
nan |
None |
10.1016/j.ejmech.2021.113817 |
| None |
ADMET |
Activity |
nan |
None |
10.1021/acs.jnatprod.0c00580 |
| None |
ADMET |
Activity |
nan |
None |
10.1021/jm201428a |
| None |
ADMET |
Alkylating activity |
0.0013 |
None |
10.1016/s0960-894x(03)00553-5 |
| None |
ADMET |
AUC |
5660.37 |
ng.hr/g |
10.1016/j.bmcl.2016.08.064 |
| None |
ADMET |
AUC |
16853.7 |
ng.hr.mL-1 |
10.1016/j.bmcl.2016.08.064 |
| None |
ADMET |
CL |
3.6 |
mL.min-1.kg-1 |
10.1124/dmd.108.020479 |
| None |
ADMET |
Cp |
3103.16 |
ng/ml |
10.1016/j.bmcl.2016.08.064 |
| None |
ADMET |
Cp |
6481.1 |
ng/ml |
10.1016/j.bmcl.2016.08.064 |
| None |
ADMET |
Cp |
12849.91 |
ng/ml |
10.1016/j.bmcl.2016.08.064 |
| None |
ADMET |
Drug uptake |
50.0 |
% |
10.1016/j.bmcl.2016.08.064 |
| None |
ADMET |
Drug uptake |
912.09 |
ng/g |
10.1016/j.bmcl.2016.08.064 |
| None |
ADMET |
Drug uptake |
2296.88 |
ng/g |
10.1016/j.bmcl.2016.08.064 |
| None |
ADMET |
Drug uptake |
4210.41 |
ng/g |
10.1016/j.bmcl.2016.08.064 |
| None |
ADMET |
Drug uptake |
nan |
None |
10.1016/j.bmcl.2016.08.064 |
| None |
ADMET |
EC50 |
51800.0 |
nM |
10.1007/s00044-010-9356-8 |
| None |
ADMET |
F |
100.0 |
% |
10.1016/j.bmcl.2016.08.064 |
| None |
ADMET |
Fu |
0.5 |
None |
10.1016/j.bmcl.2016.08.064 |
| None |
ADMET |
IC50 |
1000000.0 |
nM |
10.1016/j.bmcl.2012.04.074 |
| None |
ADMET |
MRT |
2.3 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
permeability |
nan |
None |
10.1021/acs.jmedchem.9b01328 |
| None |
ADMET |
Ratio AUC |
0.34 |
None |
10.1016/j.bmcl.2016.08.064 |
| None |
ADMET |
Ratio AUC |
20.0 |
None |
10.1016/j.bmcl.2016.08.064 |
| None |
ADMET |
Ratio AUC |
35.0 |
None |
10.1016/j.bmcl.2016.08.064 |
| None |
ADMET |
T1/2 |
0.4167 |
hr |
10.1021/jm049556d |
| None |
ADMET |
T1/2 |
1.5 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
T1/2 |
1.83 |
hr |
10.1016/j.bmcl.2021.128321 |
| None |
ADMET |
T1/2 |
1.833 |
hr |
10.1021/jm049556d |
| None |
ADMET |
T1/2 |
8.25 |
hr |
10.1021/jm00368a016 |
| None |
ADMET |
Vdss |
0.5 |
L.kg-1 |
10.1124/dmd.108.020479 |
| None |
carcinoma cell line |
IC50 |
91000.0 |
nM |
10.1021/jm049556d |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1021/tx900326k |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1124/dmd.110.035113 |
| None |
Hepatotoxicity |
HepSE_bilirubinemia |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholecystitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholelithiasis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cirrhosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_Combined Scores |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_elevated liver function tests |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic failure |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic necrosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatomegaly |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_jaundice |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver disease |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver fatty |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver function tests abnormal |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
NCI |
IC50 |
79000.0 |
nM |
10.1021/jm049556d |
| None |
NCI |
IC50 |
93000.0 |
nM |
10.1021/jm049556d |
| None |
NCI |
IC50 |
98000.0 |
nM |
10.1021/jm049556d |
| None |
NCI |
IC50 |
100000.0 |
nM |
10.1021/jm049556d |
| None |
NCI |
LC50 |
100000.0 |
nM |
10.1021/jm049556d |
| None |
NCI |
TGI |
100000.0 |
nM |
10.1021/jm049556d |
| None |
NON-PROTEIN TARGET |
Activity |
39.7 |
% |
10.1016/j.ejmech.2016.08.057 |
| None |
NON-PROTEIN TARGET |
Activity |
42.3 |
% |
10.1016/j.ejmech.2016.08.057 |
| None |
NON-PROTEIN TARGET |
Activity |
80.0 |
% |
10.1039/C2MD20047C |
| None |
NON-PROTEIN TARGET |
Activity |
nan |
None |
10.1007/s00044-011-9649-6 |
| None |
NON-PROTEIN TARGET |
Activity |
nan |
None |
10.1016/j.bmcl.2016.08.064 |
| None |
NON-PROTEIN TARGET |
Activity |
nan |
None |
10.1021/acsmedchemlett.5b00128 |
| None |
NON-PROTEIN TARGET |
Activity |
nan |
None |
10.1021/ml300132t |
| None |
NON-PROTEIN TARGET |
EC50 |
nan |
None |
10.1021/jm500660f |
| None |
NON-PROTEIN TARGET |
GI |
55.0 |
% |
10.1021/acs.jmedchem.5b01767 |
| None |
NON-PROTEIN TARGET |
GI |
nan |
None |
10.1016/j.bmcl.2016.08.064 |
| None |
NON-PROTEIN TARGET |
GI |
nan |
None |
10.1016/j.ejmech.2015.10.020 |
| None |
NON-PROTEIN TARGET |
GI50 |
50000.0 |
nM |
10.1016/j.ejmech.2016.05.004 |
| None |
NON-PROTEIN TARGET |
GI50 |
1000000.0 |
nM |
10.1016/j.ejmech.2016.05.004 |
| None |
NON-PROTEIN TARGET |
GI50 |
1000000.0 |
nM |
10.1021/jm501518y |
| None |
NON-PROTEIN TARGET |
GI50 |
nan |
None |
10.1016/j.ejmech.2016.05.004 |
| None |
NON-PROTEIN TARGET |
GI50 |
nan |
None |
10.1021/jm501518y |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (acute) |
3.0 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (animal toxicity known) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (benign tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (granulomatous hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (mechanism) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
1.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
47.5 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (time to onset) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
IC50 |
5000.0 |
nM |
10.1021/jm020936d |
| None |
NON-PROTEIN TARGET |
IC50 |
19380.0 |
nM |
10.1039/C4MD00264D |
| None |
NON-PROTEIN TARGET |
IC50 |
26000.0 |
nM |
10.1016/j.ejmech.2012.09.007 |
| None |
NON-PROTEIN TARGET |
IC50 |
49000.0 |
nM |
10.1016/j.bmcl.2012.04.074 |
| None |
NON-PROTEIN TARGET |
IC50 |
65000.0 |
nM |
10.1016/j.bmcl.2012.04.074 |
| None |
NON-PROTEIN TARGET |
IC50 |
100000.0 |
nM |
10.1021/acs.jnatprod.5b00969 |
| None |
NON-PROTEIN TARGET |
IC50 |
120000.0 |
nM |
10.1016/j.bmcl.2013.12.048 |
| None |
NON-PROTEIN TARGET |
IC50 |
200000.0 |
nM |
10.1016/j.bmcl.2014.09.087 |
| None |
NON-PROTEIN TARGET |
IC50 |
220000.0 |
nM |
10.1016/j.ejmech.2012.06.050 |
| None |
NON-PROTEIN TARGET |
IC50 |
250000.0 |
nM |
10.1021/ml300132t |
| None |
NON-PROTEIN TARGET |
IC50 |
390000.0 |
nM |
10.1016/j.bmcl.2012.04.074 |
| None |
NON-PROTEIN TARGET |
IC50 |
956000.0 |
nM |
10.1016/j.ejmech.2012.06.050 |
| None |
NON-PROTEIN TARGET |
Potency |
53.0 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
118.8 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
236.9 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Ratio |
23.0 |
None |
10.1021/jm00009a010 |
| None |
NON-PROTEIN TARGET |
TGI |
81.0 |
% |
10.1016/j.bmcl.2016.05.054 |
| None |
NON-PROTEIN TARGET |
TGI |
nan |
None |
10.1021/acs.jmedchem.5b00680 |
| None |
Non-small cell lung cancer cell line |
IC50 |
100000.0 |
nM |
10.1021/jm049556d |
| None |
No relevant target |
Drug metabolism |
0.1 |
10'-5/s |
10.1021/ml300132t |
| None |
No relevant target |
Drug metabolism |
14.0 |
10'-5/s |
10.1021/ml300132t |
| None |
No relevant target |
Drug metabolism |
46.2 |
10'-5/s |
10.1021/ml300132t |
| None |
No relevant target |
LogD7.4 |
-1.08 |
None |
10.6019/CHEMBL3301361 |
| None |
No relevant target |
LogP |
-2.8 |
None |
10.1016/j.ejmech.2009.12.043 |
| None |
No relevant target |
T1/2 |
0.42 |
hr |
10.1021/ml300132t |
| None |
No relevant target |
T1/2 |
1.24 |
hr |
10.1021/jm401121k |
| None |
No relevant target |
T1/2 |
1.38 |
hr |
10.1021/ml300132t |
| None |
No relevant target |
T1/2 |
2.0 |
hr |
10.1016/j.ejmech.2019.03.048 |
| None |
No relevant target |
T1/2 |
253.0 |
hr |
10.1021/ml300132t |
| None |
Phospholipidosis |
Phospholipidosis |
nan |
None |
10.1021/ci6004542 |
| None |
Phospholipidosis |
Phospholipidosis |
nan |
None |
10.1021/mp100103e |
| None |
Unchecked |
Ac50 |
0.3548 |
uM |
None |
| None |
Unchecked |
Ac50 |
1.0 |
uM |
None |
| None |
Unchecked |
Ac50 |
1.122 |
uM |
None |
| None |
Unchecked |
AC50 |
354.8 |
nM |
None |
| None |
Unchecked |
AC50 |
1000.0 |
nM |
None |
| None |
Unchecked |
AC50 |
1130.0 |
nM |
None |
| None |
Unchecked |
Activity |
0.27 |
% |
10.1016/j.ejmech.2021.113908 |
| None |
Unchecked |
Activity |
0.98 |
% |
10.1016/j.ejmech.2021.113908 |
| None |
Unchecked |
Activity |
2.5 |
% |
10.1016/j.ejmech.2021.113908 |
| None |
Unchecked |
Activity |
96.25 |
% |
10.1016/j.ejmech.2021.113908 |
| None |
Unchecked |
Activity |
nan |
None |
10.1016/j.bmc.2021.116533 |
| None |
Unchecked |
Activity |
nan |
None |
10.1016/j.bmcl.2016.08.064 |
| None |
Unchecked |
Activity |
nan |
None |
10.1016/j.ejmech.2013.09.040 |
| None |
Unchecked |
Activity |
nan |
None |
10.1016/j.ejmech.2019.111981 |
| None |
Unchecked |
Activity |
nan |
None |
10.1016/j.ejmech.2020.113068 |
| None |
Unchecked |
Activity |
nan |
None |
10.1016/j.ejmech.2021.113908 |
| None |
Unchecked |
Activity |
nan |
None |
10.1021/acs.jmedchem.0c00821 |
| None |
Unchecked |
Activity |
nan |
None |
10.1021/acs.jmedchem.1c00559 |
| None |
Unchecked |
Activity |
nan |
None |
10.1021/acs.jmedchem.2c00840 |
| None |
Unchecked |
Activity |
nan |
None |
10.1021/acs.jmedchem.9b00282 |
| None |
Unchecked |
EC50 |
50000.0 |
nM |
10.1021/jm500660f |
| None |
Unchecked |
FC |
0.5 |
None |
10.1021/acs.jnatprod.0c00580 |
| None |
Unchecked |
FC |
0.6 |
None |
10.1021/acs.jnatprod.0c00580 |
| None |
Unchecked |
FC |
0.7 |
None |
10.1021/acs.jnatprod.0c00580 |
| None |
Unchecked |
FC |
0.8 |
None |
10.1021/acs.jnatprod.0c00580 |
| None |
Unchecked |
FC |
0.9 |
None |
10.1021/acs.jnatprod.0c00580 |
| None |
Unchecked |
FC |
1.0 |
None |
10.1021/acs.jnatprod.0c00580 |
| None |
Unchecked |
FC |
1.1 |
None |
10.1021/acs.jnatprod.0c00580 |
| None |
Unchecked |
FC |
1.2 |
None |
10.1021/acs.jnatprod.0c00580 |
| None |
Unchecked |
FC |
1.3 |
None |
10.1021/acs.jnatprod.0c00580 |
| None |
Unchecked |
GI50 |
280200.0 |
nM |
10.1039/C6MD00384B |
| None |
Unchecked |
GI50 |
288800.0 |
nM |
10.1039/C6MD00384B |
| None |
Unchecked |
Hepatotoxicity (acute) |
1.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (association with vascular disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (choleostasis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (chronic liver disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cirrhosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (comment) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cytolytic) |
1.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (malignant tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (severe hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (steatosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (successful reintroduction) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
IC50 |
30000.0 |
nM |
10.1016/j.ejmech.2021.113908 |
| None |
Unchecked |
IC50 |
75000.0 |
nM |
10.1016/j.bmc.2017.04.049 |
| None |
Unchecked |
IC50 |
75000.0 |
nM |
10.1021/acsmedchemlett.1c00252 |
| None |
Unchecked |
IC50 |
231000.0 |
nM |
10.1021/jm401121k |
| None |
Unchecked |
IC50 |
250000.0 |
nM |
10.1021/jm401121k |
| None |
Unchecked |
IC50 |
430600.0 |
nM |
10.1021/acs.jnatprod.0c00580 |
| None |
Unchecked |
IC50 |
486900.0 |
nM |
10.1021/acs.jnatprod.0c00580 |
| None |
Unchecked |
IC50 |
624800.0 |
nM |
10.1016/j.ejmech.2019.111700 |
| None |
Unchecked |
IC50 |
666400.0 |
nM |
10.1021/acs.jnatprod.0c00580 |
| None |
Unchecked |
IC50 |
1132000.0 |
nM |
10.1016/j.ejmech.2019.111700 |
| None |
Unchecked |
Inhibition |
nan |
% |
10.1016/j.ejmech.2020.113068 |
| None |
Unchecked |
Inhibition |
nan |
% |
10.1016/j.ejmech.2021.113811 |
| None |
Unchecked |
Potency |
29092.9 |
nM |
None |
| None |
Unchecked |
Ratio CC50/EC50 |
nan |
None |
10.1016/j.ejmech.2019.111981 |
| None |
Unchecked |
Ratio IC50 |
nan |
None |
10.1016/j.ejmech.2012.06.050 |